Medication Guide App

WATSON 3211 (Rivastigmine 6 mg)

Pill imprint WATSON 3211 has been identified as Rivastigmine tartrate 6 mg.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WATSON 3211 (Rivastigmine 6 mg)

Rivastigmine tartrate 6 mg WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211
Rivastigmine tartrate
Imprint:
WATSON 3211
Strength:
6 mg
Color:
Brown & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3211
Inactive Ingredients:
silicon dioxide colloidal
hypromellose
magnesium stearate
microcrystalline cellulose
gelatin
titanium dioxide
ferric oxide yellow
ferric oxide red
ferrosoferric oxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)